Focus: Tuberculosis
- 1 December 2004
- journal article
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 2 (12) , 930-932
- https://doi.org/10.1038/nrmicro1050
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- IL-4 in tuberculosis: implications for vaccine designPublished by Elsevier ,2004
- Definition of the Beijing/W Lineage of Mycobacterium tuberculosis on the Basis of Genetic MarkersJournal of Clinical Microbiology, 2004
- Differential Monocyte Activation Underlies Strain-SpecificMycobacterium tuberculosisPathogenesisInfection and Immunity, 2004
- Increased expression of mRNA encoding interleukin (IL)‐4 and its splice variant IL‐4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulationImmunology, 2004
- Pulmonary tuberculosis in BALB/c mice with non‐functional IL‐4 genes: changes in the inflammatory effects of TNF‐α and in the regulation of fibrosisEuropean Journal of Immunology, 2003
- Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosisNature Immunology, 2003
- Inhibition of Respiration by Nitric Oxide Induces aMycobacterium tuberculosisDormancy ProgramThe Journal of Experimental Medicine, 2003
- Mutations in Putative Mutator Genes ofMycobacterium tuberculosisStrains of the W-Beijing FamilyEmerging Infectious Diseases, 2003
- A New Vaccine against Tuberculosis Affords Greater Survival after Challenge than the Current Vaccine in the Guinea Pig Model of Pulmonary TuberculosisInfection and Immunity, 2003
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001